Serum saturated fatty acids containing triacylglycerols are better markers of insulin resistance than total serum triacylglycerol concentrations
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
Aims/hypothesis The weak relationship between insulin resistance and total serum triacylglycerols (TGs) could be in part due to heterogeneity of TG molecules and their distribution within different lipoproteins. We determined concentrations of individual TGs and the fatty acid composition of serum and major lipoprotein particles and analysed how changes in different TGs and fatty acid composition are related to features of insulin resistance and abdominal obesity.Methods We performed lipidomic analyses of all major lipoprotein fractions using two analytical platforms in 16 individuals, who exhibited a broad range of insulin sensitivity.Results We identified 45 different TGs in serum. Serum TGs containing saturated and monounsaturated fatty acids were positively, while TGs containing essential linoleic acid (18:2 n-6) were negatively correlated with HOMA-IR. Specific serum TGs that correlated positively with HOMA-IR were also significantly positively related to HOMA-IR when measured in very-low-density lipoproteins (VLDLs), intermediate-density lipoproteins (IDLs) and LDL, but not in HDL subfraction 2 (HDL(2)) or 3 (HDL(3)). Analyses of proportions of esterified fatty acids within lipoproteins revealed that palmitic acid (16:0) was positively related to HOMA-IR when measured in VLDL, IDL and LDL, but not in HDL(2) or HDL(3). Monounsaturated palmitoleic (16:1 n-7) and oleic (18:1 n-9) acids were positively related to HOMA-IR when measured in HDL(2) and HDL(3), but not in VLDL, IDL or LDL. Linoleic acid was negatively related to HOMA-IR in all lipoproteins.Conclusions/interpretation Serum concentrations of specific TGs, such as TG(16:0/16:0/18:1) or TG(16:0/18:1/18:0), may be more precise markers of insulin resistance than total serum TG concentrations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Plasma saturated/unsaturated fatty acid TAGs have been found to be elevated,102,103 and associated with IR11,104 in individuals with MASLD.”
From Lipid metabolism in MASLD and MASH: From mechanism to the clinic (2024) · cites this paper as [103]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502 · cited 1×
“[26].”
The metabolic syndrome—a new worldwide definition
Alberti, K. G. M., Zimmet, P., & Shaw, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67402-8 · Cited by 9,352
Havel, R. J., Eder, H. A., & Bragdon, J. H. (1955) · Journal of Clinical Investigation · doi:10.1172/jci103182 · Cited by 8,760 · cited 1×
“Lipoprotein fractionation The lipoprotein fractions were separated by sequential flotation in an ultracentrifuge [21] (Beckman L-60; Beckman, Palo Alto, CA, USA) at 4°C by using a Ti 50.”
MethodDonnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604 · cited 2×
“In individuals with a fatty liver, the contribution of TGs derived from de novo lipogenesis to both hepatic and VLDL TGs is significantly increased [27, 31].”
BackgroundBiochemistry of Lipids, Lipoproteins and Membranes
(2021) · Elsevier eBooks · doi:10.1016/c2020-0-00089-7 · Cited by 1,400
Vessby, B., Uusitupa, M., Hermansen, K., Riccardi, G., Rivellese, A. A., Tapsell, L. C., Nälsén, C., Berglund, L., Louheranta, A., Rasmussen, B. M., et al. (2001) · Diabetologia · doi:10.1007/s001250051620 · Cited by 1,119 · cited 1×
“Dietary intervention studies have shown that an increased intake of saturated fat is associated with an increase in insulin resistance [12], whereas an increased intake of polyunsaturated fat has been shown to improve insulin sensitivity [13].”
BackgroundCeramides in insulin resistance and lipotoxicity
SUMMERS, S. (2006) · Progress in Lipid Research · doi:10.1016/j.plipres.2005.11.002 · Cited by 848 · cited 2×
“Although the bioactive lipid species represent a minor component of the lipid milieu, several lines of evidence suggest that they may play a role in, for example, inflammation [17] and antioxidative defence [18], which might contribute to atherogenity or cardioprotective properties of different lipoprotein particles.”
BackgroundMZmine: toolbox for processing and visualization of mass spectrometry based molecular profile data
Katajamaa, M., Miettinen, J., & Orešič, M. (2006) · Bioinformatics · doi:10.1093/bioinformatics/btk039 · Cited by 831 · cited 1×
“The converted data were processed using MZmine software version 0.60 [ 23 ].”
MethodInfluentialSelf-citationFatty Liver: A Novel Component of the Metabolic Syndrome
Kotronen, A., & Yki-Järvinen, H. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.147538 · Cited by 797 · cited 1×
“Insulin resistance in the liver is characterised by the inability of insulin to inhibit hepatic very-low-density lipoprotein (VLDL) production [3].”
BackgroundSelf-citationMeasurement of Plasma Glucose, Free Fatty Acid, Lactate, and Insulin for 24 h in Patients With NIDDM
Reaven, G. M., Hollenbeck, C., Jeng, C.-Y., Wu, M. S., & Chen, Y.-D. I. (1988) · Diabetes · doi:10.2337/diab.37.8.1020 · Cited by 753 · cited 1×
“Serum lipid and lipoprotein abnormalities are inherent components of the insulin resistance syndrome [1, 2].”
Background
Cited by
Human gut microbes impact host serum metabolome and insulin sensitivity
Pedersen, H. K., Gudmundsdottir, V., Nielsen, H. B., Hyotylainen, T., Nielsen, T., Jensen, B. A. H., Forslund, K., Hildebrand, F., Prifti, E., Falony, G., et al. (2016) · Nature · doi:10.1038/nature18646 · Cited by 2,116
Metabolomics for Investigating Physiological and Pathophysiological Processes
Wishart, D. S. (2019) · Physiological Reviews · doi:10.1152/physrev.00035.2018 · Cited by 1,212
“T2DM often involves a -cell deficiency coupled with peripheral insulin resistance.”
BackgroundInfluentialRhee, E. P., Cheng, S., Larson, M. G., Walford, G. A., Lewis, G. D., McCabe, E., Yang, E., Farrell, L., Fox, C. S., O’Donnell, C. J., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44442 · Cited by 647
“(28) have shown that lipid profiling of distinct lipoprotein fractions can also inform the relationship between individual lipids and insulin resistance.”
BackgroundDe novo lipogenesis in the liver in health and disease: more than just a shunting yard for glucose
Sanders, F. W. B., & Griffin, J. L. (2016) · Biological Reviews · doi:10.1111/brv.12178 · Cited by 539
“This is supported by data analysing the FA composition of TGs in subjects with and without NAFLD, showing increased levels of saturated FAs in subjects with NAFLD (Kotronen et al., 2009a,b), pointing toward DNL as the source, due to the major product of DNL being saturated FAs.”
MethodQuehenberger, O., & Dennis, E. A. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1104901 · Cited by 454
Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests
Masoodi, M., Gastaldelli, A., Hyötyläinen, T., Arretxe, E., Alonso, C., Gaggini, M., Brosnan, J., Anstee, Q. M., Millet, O., Ortiz, P., et al. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00502-9 · Cited by 451
Self-citationA Genome-wide Association Study of the Human Metabolome in a Community-Based Cohort
Rhee, E. P., Ho, J. E., Chen, M.-H., Shen, D., Cheng, S., Larson, M. G., Ghorbani, A., Shi, X., Helenius, I. T., O’Donnell, C. J., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.06.013 · Cited by 321
“We and others have previously shown that these TAGs are tightly correlated with insulin resistance, whereas TAGs with relatively higher carbon (and double-bond) content are associated with increased insulin sensitivity (Kotronen et al., 2009; Rhee et al., 2011).”
Lipid alterations in chronic liver disease and liver cancer
Paul, B., Lewinska, M., & Andersen, J. B. (2022) · JHEP Reports · doi:10.1016/j.jhepr.2022.100479 · Cited by 308
Towards metabolic biomarkers of insulin resistance and type 2 diabetes: progress from the metabolome
Roberts, L. D., Koulman, A., & Griffin, J. L. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70143-8 · Cited by 263
Dietary carbohydrate restriction improves metabolic syndrome independent of weight loss
Hyde, P. N., Sapper, T. N., Crabtree, C. D., LaFountain, R. A., Bowling, M. L., Buga, A., Fell, B., McSwiney, F. T., Dickerson, R. M., Miller, V. J., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.128308 · Cited by 210
“Serum VLDL-TGs enriched with SFAs are highly correlated with insulin resistance and adiposity (35).”
BackgroundLahti, L., Salonen, A., Kekkonen, R. A., Salojärvi, J., Jalanka-Tuovinen, J., Palva, A., Orešič, M., & de Vos, W. M. (2013) · PeerJ · doi:10.7717/peerj.32 · Cited by 196
“These fatty acids are mainly produced de novo in the liver (Westerbacka et al. 2010; Kotronen et al. 2009).”
BackgroundSelf-citationMeikle, P. J., Wong, G., Barlow, C. K., & Kingwell, B. A. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.02.001 · Cited by 184
Prediction of non-alcoholic fatty-liver disease and liver fat content by serum molecular lipids
Orešič, M., Hyötyläinen, T., Kotronen, A., Gopalacharyulu, P., Nygren, H., Arola, J., Castillo, S., Mattila, I., Hakkarainen, A., Borra, R. J. H., et al. (2013) · Diabetologia · doi:10.1007/s00125-013-2981-2 · Cited by 167
“These data are consistent with those in a much smaller group of individuals, which showed that TGs with low carbon number and double-bond content are major constituents of liver fat in human liver biopsies [11] and that these lipids are also enriched in VLDL particles of insulinresistant individuals [31].”
ResultSelf-citationOrešič, M., Seppänen‐Laakso, T., Sun, D., Tang, J. P., Therman, S., Viehman, R., Mustonen, U., van Erp, T. G., Hyötyläinen, T., Thompson, P. M., et al. (2012) · eScholarship (California Digital Library) · Cited by 168
Self-citationMetabolomics, a novel tool for studies of nutrition, metabolism and lipid dysfunction
Orešič, M. (2009) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2009.04.018 · Cited by 163
Self-citationBird, S. S., Marur, V. R., Sniatynski, M. J., Greenberg, H. K., & Kristal, B. S. (2011) · Analytical Chemistry · doi:10.1021/ac201195d · Cited by 159
Metabolome in schizophrenia and other psychotic disorders: a general population-based study
Orešič, M., Tang, J., Seppänen-Laakso, T., Mattila, I., Saarni, S. E., Saarni, S. I., Lönnqvist, J., Sysi-Aho, M., Hyötyläinen, T., Perälä, J., et al. (2011) · Genome Medicine · doi:10.1186/gm233 · Cited by 157
“In a recent lipidomic study of different lipoprotein fractions in subjects with varying degrees of insulin resistance, we found that the lipids found in LC9 are abundant in liver-produced very low density lipoprotein particles and are associated with insulin resistance [41].”
BackgroundSelf-citationZhou, Y., Orešič, M., Leivonen, M., Gopalacharyulu, P. V., Hyysalo, J., Arola, J. T., Verrijken, A., Francque, S., Gaal, L. V., Hyötyläinen, T., et al. (2016) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2016.05.046 · Cited by 168
Self-citationLipid metabolism in MASLD and MASH: From mechanism to the clinic
Carli, F., Della Pepa, G., Sabatini, S., Vidal Puig, A., & Gastaldelli, A. (2024) · JHEP Reports · doi:10.1016/j.jhepr.2024.101185 · Cited by 147
“Plasma saturated/unsaturated fatty acid TAGs have been found to be elevated, 102,103 and associated with IR 11,104 in individuals with MASLD.”
Lipidome as a predictive tool in progression to type 2 diabetes in Finnish men
Suvitaival, T., Bondia-Pons, I., Yetukuri, L., Pöhö, P., Nolan, J. J., Hyötyläinen, T., Kuusisto, J., & Orešič, M. (2018) · Metabolism · doi:10.1016/j.metabol.2017.08.014 · Cited by 146
Self-citationThe relationship between phospholipids and insulin resistance: From clinical to experimental studies
Chang, W., Hatch, G. M., Wang, Y., Yu, F., & Wang, M. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13984 · Cited by 154
Yetukuri, L., Söderlund, S., Koivuniemi, A., Seppänen-Laakso, T., Niemelä, P. S., Hyvönen, M., Taskinen, M.-R., Vattulainen, I., Jauhiainen, M., & Orešič, M. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m006494 · Cited by 134
Self-citationLiver Fat in the Pathogenesis of Insulin Resistance and Type 2 Diabetes
Yki-Järvinen, H. (2010) · Digestive Diseases · doi:10.1159/000282087 · Cited by 126
“Ceramides are known to be produced by the liver and incorporated into VLDL, and can also be found in LDL particles [”
BackgroundSelf-citationLapatto, H. A. K., Kuusela, M., Heikkinen, A., Muniandy, M., van der Kolk, B. W., Gopalakrishnan, S., Pöllänen, N., Sandvik, M., Schmidt, M. S., Heinonen, S., et al. (2023) · Science Advances · doi:10.1126/sciadv.add5163 · Cited by 124
Self-citationClinical lipidomics: realizing the potential of lipid profiling
Meikle, T. G., Huynh, K., Giles, C., & Meikle, P. J. (2021) · Journal of Lipid Research · doi:10.1016/j.jlr.2021.100127 · Cited by 135
“Untargeted lipidomics has been used to study lipidomedisease associations, such as the effect of acquired obesity (36), diet-induced weight loss (37), insulin resistance (38, 39), inflammation (39), CVD (40), and response to pharmaceutical therapies (41).”
MethodZhao, Y., Miao, H., Cheng, X., & Wei, F. (2015) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2015.09.005 · Cited by 127
Sanders, F. W. B., Acharjee, A., Walker, C., Marney, L., Roberts, L. D., Imamura, F., Jenkins, B., Case, J., Ray, S., Virtue, S., et al. (2018) · Genome Biology · doi:10.1186/s13059-018-1439-8 · Cited by 114
“Across these studies, the TAG species have in common relative enrichments for palmitate, stearate and oleate fatty acids, and studies using gas chromatography (GC)-MS have also reported associations between these FAs from total lipid extracts and increased risk of developing T2DM [15].”
BackgroundInfluentialVolk, B. M., Kunces, L. J., Freidenreich, D. J., Kupchak, B. R., Saenz, C., Artistizabal, J. C., Fernandez, M. L., Bruno, R. S., Maresh, C. M., Kraemer, W. J., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113605 · Cited by 112
“Thus, high-carbohydrate intake in individuals with an impaired ability to oxidize glucose stimulates DNL and secretion of SFA- and MUFAenriched VLDL particles; a serum profile associated with insulin resistance [7].”
BackgroundZhou, Y., Llauradó, G., Orešič, M., Hyötyläinen, T., Orho-Melander, M., & Yki-Järvinen, H. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.10.010 · Cited by 112
“The greater suppression of lipolysis by insulin in the TM6SF2 EK/KK than the TM6SF2 EE carriers implies that increased FFA delivery does not contribute to increased liver fat content or VLDL TAG synthesis.”
BackgroundInfluentialSelf-citationSerum metabolome associated with severity of acute traumatic brain injury
Thomas, I., Dickens, A. M., Posti, J. P., Czeiter, E., Duberg, D., Sinioja, T., Kråkström, M., Helmrich, I. R., Wang, K., Maas, A. I. R., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30227-5 · Cited by 119
Self-citationMetabolic signatures across the full spectrum of non-alcoholic fatty liver disease
McGlinchey, A. J., Govaere, O., Geng, D., Ratziu, V., Allison, M., Bousier, J., Petta, S., de Oliviera, C., Bugianesi, E., Schattenberg, J. M., et al. (2022) · JHEP Reports · doi:10.1016/j.jhepr.2022.100477 · Cited by 105
Self-citationLipidomics is providing new insight into the metabolic syndrome and its sequelae
Meikle, P. J., & Christopher, M. (2011) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283453dbe · Cited by 122
A comprehensive study of serum odd‐ and branched‐chain fatty acids in patients with excess weight
Mika, A., Stepnowski, P., Kaska, Ł., Proczko, M., Wiśniewski, P., Śledziński, M., & Śledziński, T. (2016) · Obesity · doi:10.1002/oby.21560 · Cited by 114
“Our findings support this hypothesis as we found a strong positive correlation between serum TG and 18:1/18:0 DI, a surrogate marker of liver SCD1 activity (10,25).”
ResultRole of Lipids in Spheroidal High Density Lipoproteins
Vuorela, T., Catte, A., Niemelä, P. S., Hall, A., Hyvönen, M. T., Marrink, S.-J., Karttunen, M., & Vattulainen, I. (2010) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000964 · Cited by 104
“The composition of the droplet has been resolved [19,20] (see Table 1), indicating free cholesterol (CHOL), cholesteryl esters (CE), triglycerides (TG), phospholipids, and lysolipids to be its main constituents, distributed such that there is a hydrophobic interior of triglycerides and cholesteryl esters and a surface…”
Kurotani, K., Sato, M., Ejima, Y., Nanri, A., Yi, S., Pham, N. M., Akter, S., Poudel‐Tandukar, K., Kimura, Y., Imaizumi, K., et al. (2012) · Nutrition Research · doi:10.1016/j.nutres.2012.07.004 · Cited by 100
“Several studies demonstrated no clear association of long-chain n-3 fatty acids (EPA and DHA) to insulin resistance [6,11] and type 2 diabetes [5,7,12,14], whereas other studies found either inverse [31] or positive [9,10] associations.”
BackgroundResultInfluentialStåhlman, M., Pham, H. T., Adiels, M., Mitchell, T. W., Blanksby, S. J., Fagerberg, B., Ekroos, K., & Borén, J. (2012) · Diabetologia · doi:10.1007/s00125-011-2444-6 · Cited by 107
“Furthermore, they also showed that TAG 16:0 – 16:0 – 18:1 and TAG 16:0 – 18:1 – 18:0 are better markers of insulin resistance than total serum TAG concentration [32].”
Self-citationKulkarni, H. R., Meikle, P. J., Mamtani, M., Weir, J. M., Barlow, C. K., Jowett, J. B. M., Bellis, C., Dyer, T. D., Johnson, M. P., Rainwater, D. L., et al. (2013) · Hypertension · doi:10.1161/hypertensionaha.113.01396 · Cited by 103
“It is noteworthy that serum lipidomic studies have already offered critical insights in the pathogenesis of complex diseases, such as obesity and insulin resistance.(22,25,26) Initial studies in relation to hypertension have also been very encouraging, although generally limited by small sample sizes and lower resolut…”
BackgroundLankinen, M. A., Schwab, U., Kolehmainen, M., Paananen, J., Nygrén, H., Seppänen‐Laakso, T., Poutanen, K. S., Hyötyläinen, T., Risérus, U., Savolainen, M. J., et al. (2016) · Journal of Nutrition · doi:10.3945/jn.115.220459 · Cited by 110
Self-citationMetabolomics based markers predict type 2 diabetes in a 14-year follow-up study
Liu, J., Semiz, S., van der Lee, S. J., van der Spek, A., Verhoeven, A., van Klinken, J. B., Sijbrands, E., Harms, A. C., Hankemeier, T., van Dijk, K. W., et al. (2017) · Metabolomics · doi:10.1007/s11306-017-1239-2 · Cited by 92
“Despite the fact that LASSO regression method is used to select independent components of our model, various metabolites from the same biochemical class were selected, supporting the view that the sub-fractions of some classical measurements play independent functions in the pathogenesis of type 2 diabetes (Kotronen e…”
MethodOptimizing the lipidomics workflow for clinical studies—practical considerations
Hyötyläinen, T., & Orešič, M. (2015) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-015-8633-2 · Cited by 100
“LysoPCs and ether-linked PCs have been found in all lipoprotein fractions, with the greatest abundances in HDL subfraction 2, HDL subfraction 3, and LDL [90].”
InfluentialSelf-citationForsythe, C. E., Phinney, S. D., Feinman, R. D., Volk, B. M., Freidenreich, D., Quann, E., Ballard, K., Puglisi, M. J., Maresh, C. M., Kraemer, W. J., et al. (2010) · Lipids · doi:10.1007/s11745-010-3467-3 · Cited by 90
“Higher incorporation of SFA into VLDL TAG is correlated with insulin resistance and adiposity [27], probably reflecting accelerated hepatic de novo lipogenesis.”
BackgroundMicroglia activation due to obesity programs metabolic failure leading to type two diabetes
Maldonado-Ruiz, R., Montalvo-Martínez, L., Fuentes-Mera, L., & Camacho, A. (2017) · Nutrition & Diabetes · doi:10.1038/nutd.2017.10 · Cited by 86
Alterations of specific lipid groups in serum of obese humans: a review
Mika, A., & Śledziński, T. (2016) · Obesity Reviews · doi:10.1111/obr.12475 · Cited by 91
“However, the association between the activity of SCD1 in adipose tissue and serum DI is much weaker than for the liver desaturase (13,276).”
BackgroundSystems biology strategies to study lipidomes in health and disease
Hyötyläinen, T., & Orešič, M. (2014) · Progress in Lipid Research · doi:10.1016/j.plipres.2014.06.001 · Cited by 90
Self-citationBonci, E., Chiesa, C., Versacci, P., Anania, C., Silvestri, L., & Pacifico, L. (2015) · BioMed Research International · doi:10.1155/2015/213737 · Cited by 81
Westerbacka, J., Kotronen, A., Fielding, B. A., Wahren, J., Hodson, L., Perttilä, J., Seppänen‐Laakso, T., Suortti, T., Arola, J. T., Hultcrantz, R. W., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.06.064 · Cited by 84
Self-citationLeskinen, T., Rinnankoski-Tuikka, R., Rintala, M., Seppänen-Laakso, T., Pöllänen, E., Alen, M., Sipilä, S., Kaprio, J., Kovanen, V., Rahkila, P., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012609 · Cited by 75
Self-citationBioactive Nutrients and Nutrigenomics in Age-Related Diseases
Rescigno, T., Micolucci, L., Tecce, M., & Capasso, A. (2017) · Molecules · doi:10.3390/molecules22010105 · Cited by 74
Hyysalo, J., Gopalacharyulu, P., Bian, H., Hyötyläinen, T., Leivonen, M., Jaser, N., Juuti, A., Honka, M.-J., Nuutila, P., Olkkonen, V. M., et al. (2014) · Diabetes · doi:10.2337/db13-0774 · Cited by 62
“esterified fatty acids were positively correlated with insulin resistance, and those of essential fatty acids were inversely correlated with insulin resistance (48).”
BackgroundSelf-citationGuerra, S., Mocciaro, G., & Gastaldelli, A. (2021) · European Journal of Clinical Investigation · doi:10.1111/eci.13695 · Cited by 65
Lipidomics as a Tool for the Study of Lipoprotein Metabolism
Kontush, A., & Chapman, M. J. (2010) · Current Atherosclerosis Reports · doi:10.1007/s11883-010-0100-0 · Cited by 66
Systems biology approaches to study lipidomes in health and disease
Alves, M. A., Lamichhane, S., Dickens, A. M., McGlinchey, A. J., Ribeiro, H. C., Sen, P., Wei, F., Hyötyläinen, T., & Orešič, M. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2020.158857 · Cited by 65
Self-citationChu, X., Liu, L., Na, L., Lu, H., Li, S., Li, Y., & Sun, C. (2013) · Diabetes · doi:10.2337/db12-0139 · Cited by 63
“PA is correlated positively with HOMAIR (46).”
Non-alcoholic Fatty Liver Disease and Its Links with Inflammation and Atherosclerosis
Abdallah, L. R., de Matos, R. C., Souza, Y. P. D. M. E., Soares, D. V., Muller-Machado, G., & Pollo‐Flores, P. (2020) · Current Atherosclerosis Reports · doi:10.1007/s11883-020-0820-8 · Cited by 61
Mocciaro, G., Allison, M., Jenkins, B., Azzu, V., Huang-Doran, I., Herrera-Marcos, L. V., Hall, Z., Murgia, A., Susan, D., Frontini, M., et al. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2023.101728 · Cited by 56
Geng, D., Musse, A. A., Wigh, V., Carlsson, C., Engwall, M., Orešič, M., Scherbak, N. N., & Hyötyläinen, T. (2018) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2018.12.040 · Cited by 56
Self-citationMamtani, M., Kulkarni, H. R., Wong, G., Weir, J. M., Barlow, C. K., Dyer, T. D., Almasy, L. A., Mahaney, M. C., Comuzzie, A. G., Glahn, D. C., et al. (2016) · Lipids in Health and Disease · doi:10.1186/s12944-016-0234-3 · Cited by 63
“New high-throughput and high-resolution technologies applied to plasma lipidomic profiling are now providing additional insights into disease pathophysiology and individual lipid species have been associated with existing T2D or prediabetes [4–7].”
BackgroundMcGranaghan, P., Kirwan, J., García-Rivera, M. A., Pieske, B. M., Edelmann, F., Blaschke, F., Appunni, S., Saxena, A., Rubens, M., Veledar, E., et al. (2021) · Metabolites · doi:10.3390/metabo11090621 · Cited by 57
Mocciaro, G., D’Amore, S., Jenkins, B., Kay, R. G., Murgia, A., Herrera-Marcos, L. V., Neun, S., Sowton, A. P., Hall, Z., Palma-Duran, S. A., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126786 · Cited by 55
“Last, our results (despite finding multiple lines of validation in the literature [18,19,26,27,44,65,66]) will require validation in a larger study cohort to prove the transferability of our main findings to clinical practice.”
ResultNivala, A. M., Reese, L., Frye, M. A., Gentile, C. L., & Pagliassotti, M. J. (2013) · Metabolism · doi:10.1016/j.metabol.2012.12.001 · Cited by 60
“…particularly relevant given that previous human studies have suggested that a) saturated fatty acids have selective effects on hepatic glucose metabolism [19] and b) serum saturated fatty acid-containing triglycerides may be better markers of insulin resistance than total serum triglycerides [20].”
Bergman, B. C., Howard, D., Schauer, I. E., Maahs, D. M., Snell-Bergeon, J. K., Clement, T. W., Eckel, R. H., Perreault, L., & Rewers, M. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2892 · Cited by 51
“(16) recently reported that whole-body insulin resistance in healthy humans related to triglyceride in plasma low-density lipoprotein, intermediate-density lipoprotein, and very low-density lipoprotein containing more saturated acyl groups, and not total triglyceride concentration.”
BackgroundA Mendelian Randomization Study of Metabolite Profiles, Fasting Glucose, and Type 2 Diabetes
Liu, J., van Klinken, J. B., Semiz, S., van Dijk, K. W., Verhoeven, A., Hankemeier, T., Harms, A. C., Sijbrands, E. J. G., Sheehan, N. A., van Duijn, C. M., et al. (2017) · Diabetes · doi:10.2337/db17-0199 · Cited by 56
“Metabolomics Center, Leiden using the method described before (18); (2) ElectrosprayIonization MS (ESI-MS, in total 148 phospholipids and sphingolipids comprising of 16 plasmologens, 72 phosphatidylcholines, 27 phosphatidylethanolamines, 24 sphingolipids,”
BackgroundMethodNevalainen, J., Sairanen, M., Appelblom, H., Gissler, M., Timonen, S., & Ryynänen, M. (2016) · The Review of Diabetic Studies · doi:10.1900/rds.2016.13.236 · Cited by 55
“Metabolites associated with T2DM include carbohydrates, lipids like lyso-phosphatidylcholines [17,18], fatty acids [19], acylcarnitines [20], and amino acids, particularly branched-chain amino acids (BCAAs, leucine, isoleucine, and valine) and aromatic amino acids (phenylalanine and tyrosine) [16].”
BackgroundShin, J., Nam, M. H., Lee, H.-R., Lee, J., Kim, H., Chung, M.-J., & Seo, J. (2017) · European Journal of Nutrition · doi:10.1007/s00394-017-1481-4 · Cited by 54
“Serum TAGs (16:0/16:0/18:1)—including saturated and monosaturated FAs—and TAG (16:0/16:0/18:0) were positively correlated with the homeostasis model assessment of insulin resistance (HOMA-IR), suggesting that these specific TAGs may be more precise markers of insulin resistance than total serum TAG concentration [34].”
BackgroundMetabolomics and ischaemic heart disease
Rasmiena, A. A., Ng, T. W., & Meikle, P. J. (2012) · Clinical Science · doi:10.1042/cs20120268 · Cited by 49
Bermúdez-Cardona, J., & Velásquez, C. (2016) · Nutrients · doi:10.3390/nu8020054 · Cited by 56
“ARA arachidonic acid AW appropriate weight BMI Body Mass Index CE cholesterol ester HDL-C high-density lipoprotein LDL-C low-density lipoprotein DHA docosahexaenoic acid DHGL dihomo-γ-linolenic acid DM diabetes mellitus FA fatty acid FFA free fatty acid HOMA Homeostasis Model Assessment hsCRP high-sensitivity C-reacti…”
BackgroundInfluentialLipidomic profiling reveals early-stage metabolic dysfunction in overweight or obese humans
Mousa, A., Naderpoor, N., Mellett, N. A., Wilson, K., Plebanski, M., Meikle, P. J., & de Courten, B. V. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2018.12.014 · Cited by 53
Yetukuri, L., Huopaniemi, I., Koivuniemi, A., Maranghi, M., Hiukka, A., Nygrén, H., Kaski, S., Taskinen, M., Vattulainen, I., Jauhiainen, M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023589 · Cited by 49
Self-citationMultivariate multi-way analysis of multi-source data
Huopaniemi, I., Suvitaival, T., Nikkilä, J., Orešič, M., & Samuel Kaski, A. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq174 · Cited by 45
Self-citationBernardi, J. R., Ferreira, C. F., Senter, G., Krolow, R., de Aguiar, B. W., Portella, A. K., Kauer-Sant'Anna, M., Kapczinski, F., Dalmaz, C., Goldani, M. Z., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062031 · Cited by 43
“Palmitoleic acid is associated with increased insulin concentrations [55] and resistance [56] [57] [58] [59] [60] [61] [62], type II diabetes [63] [64], metabolic syndrome [61] [65] [66], heart failure [67] and coronary heart disease [68].”
BackgroundBei, F., Jia, J., Jia, Y., Sun, J., Liang, F., Yu, Z., & Cai, W. (2015) · Lipids in Health and Disease · doi:10.1186/s12944-015-0094-2 · Cited by 54
“Both these fatty acids also positively correlated with IR index in adult rats, consistent with the fact that both have been previously suggested as diagnostic biomarkers for IR [17, 61].”
BackgroundResultWentworth, J. M., Naselli, G., Ngui, K., Smyth, G. K., Liu, R., O’Brien, P. E., Bruce, C. R., Weir, J. M., Cinel, M. A., Meikle, P. J., et al. (2015) · International Journal of Obesity · doi:10.1038/ijo.2015.223 · Cited by 46
Zhang, X., Huang, L., Su, H., Chen, Y., Huang, J., He, C., Li, P., Yang, D., & Wan, J. (2014) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2014.02.014 · Cited by 41
Lipid profiling of lipoproteins by electrospray ionization tandem mass spectrometry
Scherer, M., Böttcher, A., & Liebisch, G. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.06.016 · Cited by 40
Lipidomics in the Study of Hypertension in Metabolic Syndrome
Kulkarni, H., Mamtani, M., Blangero, J., & Curran, J. (2017) · Current Hypertension Reports · doi:10.1007/s11906-017-0705-6 · Cited by 27
Bioanalytical Techniques in Nontargeted Clinical Lipidomics
Hyötyläinen, T., & Orešič, M. (2016) · Bioanalysis · doi:10.4155/bio.15.244 · Cited by 41
Self-citationSuvitaival, T., Mantere, O., Kieseppä, T., Mattila, I. M., Pöhö, P., Hyötyläinen, T., Suvisaari, J., & Orešič, M. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.222 · Cited by 44
Self-citationPlasma dihydroceramide species associate with waist circumference in Mexican American families
Mamtani, M., Meikle, P. J., Kulkarni, H. R., Weir, J. M., Barlow, C. K., Jowett, J. B. M., Bellis, C., Dyer, T. D., Almasy, L. A., Mahaney, M. C., et al. (2013) · Obesity · doi:10.1002/oby.20598 · Cited by 40
“Of special interest, plasma lipid species as measured by lipidomic profiling are being increasingly associated with the risk of T2D/IR and have been shown to be better predictors than the lipoprotein fractions that are commonly used in clinical practice (26-28).”
BackgroundDraisma, H. H. M., Reijmers, T. H., Meulman, J. J., van der Greef, J., Hankemeier, T., & Boomsma, D. I. (2012) · European Journal of Human Genetics · doi:10.1038/ejhg.2012.110 · Cited by 37
Wu, G., Cheng, H., Guo, H., Li, Z., Li, D., & Xie, Z. (2023) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2023.109349 · Cited by 42
Metabolomics applied to diabetes−lessons from human population studies
Liggi, S., & Griffin, J. L. (2017) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2017.10.011 · Cited by 39
Informatics and computational strategies for the study of lipids
Orešič, M. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.06.012 · Cited by 42
Self-citationThe Use of High-Throughput Technologies to Investigate Vascular Inflammation and Atherosclerosis
Döring, Y., Noels, H., & Weber, C. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.232686 · Cited by 36
Lana-Elola, E., Cater, H., Watson-Scales, S., Greenaway, S., Müller-Winkler, J., Gibbins, D., Nemes, M., Slender, A., Hough, T., Keskivali-Bond, P., et al. (2021) · Disease Models & Mechanisms · doi:10.1242/dmm.049157 · Cited by 35
“Decreased levels of LPC phospholipids and increased triglycerides are associated with a pre-diabetic state (Barber et al., 2012; Ferrannini et al., 2013; Kotronen et al., 2009; Suvitaival et al., 2018; Wang-Sattler et al., 2012).”
BackgroundLipidomics in biomedical research-practical considerations
Hyötyläinen, T., Ahonen, L. L., Pöhö, P., & Orešič, M. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2017.04.002 · Cited by 35
“using stable isotope tracers or focusing on lipidomic profiling in isolated lipoprotein fractions [28-30], are highly important if one is to interpret lipidomic profiles in the physiological context.”
MethodSelf-citationCastañé, H., Baiges‐Gayà, G., Hernández‐Aguilera, A., Rodríguez‐Tomàs, E., Fernández‐Arroyo, S., Herrero, P., Delpino-Rius, A., Canela-Canela, N., Menéndez, J. A., Camps, J., et al. (2021) · Biomolecules · doi:10.3390/biom11030473 · Cited by 36
Kopprasch, S., Dheban, S., Schuhmann, K., Xu, A., Schulte, K., Simeonovic, C. J., Schwarz, P. E. H., Bornstein, S. R., Shevchenko, A., & Graessler, J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0164173 · Cited by 35
Seah, J. Y. H., Ong, C. N., Koh, W., Yuan, J., & van Dam, R. M. (2019) · Journal of Nutrition · doi:10.1093/jn/nxz164 · Cited by 34
Bondia‐Pons, I., Pöhö, P., Bozzetto, L., Vetrani, C., Patti, L., Aura, A., Annuzzi, G., Hyötyläinen, T., Rivellese, A. A., & Orešič, M. (2014) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201400155 · Cited by 33
“Total plasma was characterized by a higher number of highly unsaturated long-chain TGs and a lower number of plasmalogens than the HDL fraction, as previously described [19].”
ResultSelf-citationLipidomics, Biomarkers, and Schizophrenia: A Current Perspective
Sethi, S., Hayashi, M. A. F., Correia, B. S. B., Pontes, J. G. D. M., Tasić, L., & Brietzke, E. M. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-47656-8_11 · Cited by 30
LRRK2 and Lipid Pathways: Implications for Parkinson’s Disease
Galper, J., Kim, W. S., & Dzamko, N. L. (2022) · Biomolecules · doi:10.3390/biom12111597 · Cited by 30
“Serum triacylglycerol comprising 16:0 from very low, low and intermediate density lipoprotein has previously been shown to positively correlate to an indicator of insulin resistance (HOMA-IR) and may be a better marker of insulin resistance than total serum triacylglycerol concentrations [73].”
BackgroundWang, S., Link, F., Han, M., Chaudhary, R., Asimakopoulos, A., Liebe, R., Yao, Y., Hammad, S., Dropmann, A., Krizanac, M., et al. (2023) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.12.012 · Cited by 31
Hypercoagulation and elevation of blood triglycerides are characteristics of Kawasaki disease
Chen, X., Zhao, Z., Li, L., Chen, X., Xu, H., Lou, J., Li, L., Du, L., & Xie, C. (2015) · Lipids in Health and Disease · doi:10.1186/s12944-015-0167-2 · Cited by 31
“Certain species of TG were attributed to childhood obesity [38] and insulin resistance [39].”
BackgroundMetabolomic strategies to study lipotoxicity in cardiovascular disease
Waterman, C. L., Cheng, K., & Griffin, J. L. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.11.004 · Cited by 28
Lai, M., Fang, F., Ma, Y., Yang, J., Huang, J., Li, N., Kang, M., Xu, X., Zhang, J., Wang, Y., et al. (2020) · Journal of Diabetes Research · doi:10.1155/2020/3950652 · Cited by 32
“Free fatty acids (FFAs) potentially derived from elevated TGs might decrease insulin sensitivity, creating a vicious cycle between TG levels and insulin resistance [8, 34, 35].”
BackgroundAkıncı, B., Subauste, A. R., Ajluni, N., Esfandiari, N. H., Meral, R., Neidert, A., Eraslan, A., HENCH, R. P., Rus, D., McKenna, B. J., et al. (2021) · Med · doi:10.1016/j.medj.2021.04.001 · Cited by 33
Urpí-Sardà, M., Almanza‐Aguilera, E., Tulipani, S., Tinahones, F. J., Salas‐Salvadó, J., & Andrés‐Lacueva, C. (2015) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-015-0440-y · Cited by 33
Yu, Z., Mao, C., Fu, X., & Ma, M. (2018) · Food Science of Animal Resources · doi:10.5851/kosfa.2018.e38 · Cited by 27
Mechanistic insights revealed by lipid profiling in monogenic insulin resistance syndromes
Eiden, M., Koulman, A., Hatunic, M., West, J. A., Murfitt, S. A., Osei, M., Adams, C., Wang, X., Chu, Y., Marney, L. C., et al. (2015) · Genome Medicine · doi:10.1186/s13073-015-0179-6 · Cited by 30
“Discussion The relative enrichment in shorter chain saturated TAG species observed in samples from the LD group is remarkably similar to that recently shown to be associated with IR in a large epidemiological study [1] and smaller selected cohort studies [2, 20].”
BackgroundResultInfluentialCurrent Progress of Lipid Analysis in Metabolic Diseases by Mass Spectrometry Methods
Mika, A., Śledziński, T., & Stepnowski, P. (2017) · Current Medicinal Chemistry · doi:10.2174/0929867324666171003121127 · Cited by 26
Metadata
- Authors
- Kotronen, A., Velagapudi, V. R., Yetukuri, L., Westerbacka, J., Bergholm, R., Ekroos, K., Makkonen, J., Taskinen, M.-R., Orešič, M., & Yki-Järvinen, H.
- Affiliations
- Helsinki University Hospital (FI)
- VTT Technical Research Centre of Finland (FI)
- Corresponding author
- Orešič, M.
- Venue
- Diabetologia
- Published
- 2009-02-13
- Volume
- 52
- Issue
- 4
- Pages
- 684-690
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2016785044
- Cited by
- 198
- References
- 48
- Citations by year
- 2026: 4 · 2025: 8 · 2024: 10 · 2023: 12 · 2022: 9 · 2021: 16 · 2020: 7 · 2019: 9 · 2018: 8 · 2017: 18 · 2016: 17 · 2015: 11 · 2014: 11 · 2013: 17 · 2012: 15
- FWCI
- 9.92
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Foundation for Cardiovascular Research
- Jalmari ja Rauha Ahokkaan Säätiö
- European Commission (LSHM‐CT‐2005‐018734)
- Academy of Finland
- Novo Nordisk
- Sydäntutkimussäätiö
- Aarne ja Aili Turusen Säätiö
- Novo Nordisk Fonden
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Keywords
- insulin resistance, serum triglycerides, saturated fatty acids, monounsaturated fatty acids, linoleic acid, lipoproteins, VLDL, intermediate density lipoprotein, low-density lipoprotein, HDL subfractions, palmitic acid, palmitoleic acid, oleic acid, HOMA-IR, abdominal obesity, lipidomics, biomarkers
- MeSH terms
- Adult, Fasting, Fatty Acids, Female, Humans, Insulin Resistance, Cholesterol, HDL, Cholesterol, LDL, Male, Middle Aged, Reference Values, Triglycerides, Biomarkers, Body Mass Index
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.